Non Invasive Electrical Impedance Technology (EIT) for Diagnosing Liver Diseases Severity
Launched by PROF. ZIV BEN-ARI MD · Apr 3, 2018
Trial Information
Current as of July 03, 2025
Unknown status
Keywords
ClinConnect Summary
The study will include 210 patients with chronic liver diseases. Relevant clinical data such as sex, age, weight, height, alcohol intake, medical history and routine lab results will be collected.
The study will include three groups:
1. Patients with indication for liver biopsy will undergo a routine liver biopsy and also routine liver Ultrasonography, Shear wave elastography and Electrical Impedance Technology (EIT) (70 patients).
2. Patients with chronic liver diseases will undergo routine liver Ultrasonography, Shear wave elastography and Electrical Impedance Technology (EIT) (70 patie...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Patients with chronic liver diseases
- Exclusion Criteria:
- • Patients who don't have chronic liver diseases
About Prof. Ziv Ben Ari Md
Professor Ziv Ben-Ari, MD, is a distinguished clinical trial sponsor known for his expertise in neurological research and innovative therapeutic approaches. With a robust background in medicine and an emphasis on translational research, he leads initiatives that aim to advance understanding and treatment of neurological disorders. His commitment to improving patient outcomes is reflected in the design and execution of clinical trials that prioritize safety, efficacy, and ethical standards. Professor Ben-Ari's collaborative approach fosters partnerships with leading institutions and researchers, positioning him as a pivotal figure in the advancement of medical science.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Patients applied
Trial Officials
Ziv Ben-Ari, MD
Principal Investigator
Sheba Medical Center
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials